Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Non-cash Items: 2022-2025

Historic Non-cash Items for Roivant Sciences (ROIV) over the last 4 years, with Mar 2025 value amounting to $110.7 million.

  • Roivant Sciences' Non-cash Items rose 7.94% to $113.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $113.0 million, marking a year-over-year increase of 7.94%. This contributed to the annual value of $110.7 million for FY2025, which is 13.92% up from last year.
  • Latest data reveals that Roivant Sciences reported Non-cash Items of $110.7 million as of FY2025, which was up 2.99% from $107.5 million recorded in FY2024.
  • Roivant Sciences' 5-year Non-cash Items high stood at $110.7 million for FY2025, and its period low was $1.9 million during FY2022.
  • For the 3-year period, Roivant Sciences' Non-cash Items averaged around $94.4 million, with its median value being $97.2 million (2024).
  • Data for Roivant Sciences' Non-cash Items shows a peak YoY spiked of 3,318.42% (in 2023) over the last 5 years.
  • Over the past 4 years, Roivant Sciences' Non-cash Items (Yearly) stood at $1.9 million in 2022, then reached $55.6 million in 2022, then skyrocketed by 3,318.42% to $64.9 million in 2023, then surged by 64.78% to $91.7 million in 2023, then spiked by 49.67% to $97.2 million in 2024, then increased by 17.24% to $107.5 million in 2024, then rose by 13.92% to $110.7 million in 2025.